STRATEGIES FOR REPLACEMENT THERAPY FOR EXOCRINE PANCREATIC INSUFFICIENCY: A PHARMACOECONOMIC ANALYSIS

Download full text PDF
Issue: 
1
Year: 
2015

V. Ryazhenov (1,2), Candidate of Medical Sciences; S. Maksimkin (2) 1 -I.M. Sechenov First Moscow Medical University 2 -Center for Strategic Studies in Public Health

A comparative pharmacoeconomic assessment of different strategies for pharmacotherapy was made in patients with chronic pancreatitis and exocrine pancreatic insufficiency in an inpatient setting. It demonstrated the clinical and economic benefits of Ermital.

Keywords: 
chronic pancreatitis
exocrine pancreatic insufficiency
pancreatin preparations
Creon
Ermital
Mezym forte 10 000
pharmacoeconomic analysis
simulation
cost-effectiveness



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Maev I.V., Kucherjavyj Ju.A., Moskaleva A.B. Hronicheskij pankreatit: mify 1. i realii // Farmateka. – 2010; 12: 24–31.
  2. L2. öhr J., Hummel F., Pirilis K. et al. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency// Eur. J. Gastroenterol. Hepatol. – 2009; 21: 1024–31.
  3. Mayerle J., Hoffmeister A., Werner J. et al. Chronic pancreatitis – definition, etiology, investigation and treatment // Dtsch. Arztebl. Int. – 2013; 110: 387–93.
  4. FDA Guidance for Industry. Exocrine Pancreatic Insufficiency Drug Products –Submitting New Drug Applications, U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), April 2006, www.fda.gov
  5. Jakovenko A.V., Jakovenko E.P. Hronicheskij pankreatit. Prakticheskie k terapii // Bolezni organov pischevarenija (dlja spetsialistov i vrachej obschej praktiki). Biblioteka RMZh, 2007; (T. 9, 2): 48–51.
  6. Maev I.V., Kucherjavyj Ju.A. Sovremennye preparaty pankreatina v klinicheskoj praktike // Trudnyj patsient – 2009; 11 (7): 49–56.
  7. Maev I.V., Kucherjavyj Ju.A. Sovremennye preparaty pankreatina v klinicheskoj praktike // Consilium Medicum – 2009; 2: 1–4.
  8. Minushkin O.N. Hronicheskij pankreatit: epidemiologija, etiologija, klassifikatsija // Farmateka. – 2007; 2: 53–6.
  9. Grinevich V.B., Sablin O.A., Bogdanov I.V. Klinicheskie i farmakoekonomicheskie aspekty polifermentnoj zamestitel'noj terapii // Klin. perspekt. v gastroenterol., gepatol. – 2004; 2: 16–23.
  10. Maev I.V., Kucherjavyj Ju.A. i dr. Farmakoekonomicheskaja effektivnost' 10. zamestitel'noj terapii razlichnymi preparatami pankreatina u bol'nyh hronicheskim pankreatitom s ekzokrinnoj pankreaticheskoj nedostatochnost'ju // Farmateka. – 2010; 15: 98–104.
  11. Maev I.V., Kucherjavyj Ju.A. i dr. Farmakoekonomicheskie pokazateli zamestitel'noj fermentnoj terapii ekzokrinnoj pankreaticheskoj nedostatochnosti // Klin. perspekt. gastroenterol., gepatol. – 2011; 4: 18–25.